The BIT drug trial mentions no effect on CD4+ T cells which are the main barrier to a cure.
https://www.genengnews.com/topics/g...tent-hiv-1-offering-hope-of-functional-cures/
CD4+ T cells have been the most studied of the cellular reservoirs in which HIV-1 can persist. A small fraction of resting CD4+ T cells will harbor HIV-1, even during ART, and are considered to be “the major obstacle to HIV-1 eradication,” the authors point out. “Latent HIV-1 infection in resting CD4+ T cells is the primary cause of the barrier to a functional cure.”
$10 Billion Deal, page-130
-
- There are more pages in this discussion • 13,137 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
